Effect of short-term administration of garlic supplements on single-dose ritonavir pharmacokinetics in healthy volunteers

被引:82
作者
Gallicano, K
Foster, B
Choudhri, S
机构
[1] Clin Invest Unit, Ottawa, ON, Canada
[2] Ottawa Hosp, Inst Res, Ottawa, ON, Canada
[3] Hlth Canada, Therapeut Prod Directorate, Ottawa, ON K1A 0L2, Canada
[4] Univ Manitoba, Dept Med, Winnipeg, MB R3T 2N2, Canada
[5] Univ Manitoba, Dept Microbiol, Winnipeg, MB R3T 2N2, Canada
[6] St Boniface Gen Hosp, Winnipeg, MB R2H 2A6, Canada
关键词
garlic supplements; pharmacokinetic interaction; ritonavir;
D O I
10.1046/j.1365-2125.2003.01736.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aims To evaluate the effect of acute dosing of garlic supplements on the single-dose pharmacokinetics of ritonavir. Methods Ten healthy volunteers (five male, five female) were equally randomized in a crossover design to receive 400 mg of a single dose of ritonavir within 10 min after eating breakfast either alone or with 10 mg of Natural Source Odourless Garlic. They received a total of eight doses of garlic extract (2 x 5 mg capsules) taken twice daily for 4 days. Ritonavir and the seventh garlic dose were administered simultaneously. Resulst Coadministration of garlic nonsignificantly decreased area under the plasma concentration-time curve (AUC(0,infinity)) by -17% (90% confidence interval (CI), -31% to 0%; range -46% to 68%) and peak plasma concentration of ritonavir by -1% (90% CI, -25% to 31%; range -51% to 136%). Conclusions Acute dosing of the garlic capsules over 4 days did not significantly alter the single-dose pharmacokinetics of ritonavir in healthy volunteers. Given the complex effects of both ritonavir and garlic on drug metabolism, the results of our study should not be extrapolated to steady-state conditions, where the possibility of an interaction still needs to be evaluated.
引用
收藏
页码:199 / 202
页数:4
相关论文
共 8 条
[2]  
Foster BC, 2001, J PHARM PHARM SCI, V4, P176
[3]   MODIFICATION OF HEPATIC DRUG-METABOLIZING-ENZYMES IN RAT FED NATURALLY-OCCURRING ALLYL SULFIDES [J].
HABER, D ;
SIESS, MH ;
DEWAZIERS, I ;
BEAUNE, P ;
SUSCHETET, M .
XENOBIOTICA, 1994, 24 (02) :169-182
[4]   Ritonavir - Clinical pharmacokinetics and interactions with other anti-HIV agents [J].
Hsu, A ;
Granneman, GR ;
Bertz, RJ .
CLINICAL PHARMACOKINETICS, 1998, 35 (04) :275-291
[5]   Effect of ketoconazole on ritonavir and saquinavir concentrations in plasma and cerebrospinal fluid from patients infected with human immunodeficiency virus [J].
Khaliq, Y ;
Gallicano, K ;
Venance, S ;
Kravcik, S ;
Cameron, DW .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 68 (06) :637-646
[6]  
Laroche M, 1998, CAN J INFECT DIS MED, V9, p471P
[7]   IDENTIFICATION AND HPLC QUANTITATION OF THE SULFIDES AND DIALK(EN)YL THIOSULFINATES IN COMMERCIAL GARLIC PRODUCTS [J].
LAWSON, LD ;
WANG, ZYJ ;
HUGHES, BG .
PLANTA MEDICA, 1991, 57 (04) :363-370
[8]   The effect of garlic supplements on the pharmacokinetics of saquinavir [J].
Piscitelli, SC ;
Burstein, AH ;
Welden, N ;
Gallicano, KD ;
Falloon, J .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (02) :234-238